These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30743190)

  • 21. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease.
    Griffin MR; Coffey CS; Neuzil KM; Mitchel EF; Wright PF; Edwards KM
    Arch Intern Med; 2002 Jun; 162(11):1229-36. PubMed ID: 12038940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.
    Oh PI; Lanctôt KL; Yoon A; Lee DS; Paes BA; Simmons BS; Parison D; Manzi P;
    Pediatr Infect Dis J; 2002 Jun; 21(6):512-8. PubMed ID: 12182374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond randomized controlled trials: a "real life" experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab.
    Mitchell I; Tough S; Gillis L; Majaesic C
    Pediatr Pulmonol; 2006 Dec; 41(12):1167-74. PubMed ID: 17058279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T; Rozé JC; Fauroux B;
    Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social, economic, and health impact of the respiratory syncytial virus: a systematic search.
    Díez-Domingo J; Pérez-Yarza EG; Melero JA; Sánchez-Luna M; Aguilar MD; Blasco AJ; Alfaro N; Lázaro P
    BMC Infect Dis; 2014 Oct; 14():544. PubMed ID: 25358423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
    Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003-2011.
    Goldstein E; Greene SK; Olson DR; Hanage WP; Lipsitch M
    Influenza Other Respir Viruses; 2015 Sep; 9(5):225-33. PubMed ID: 25980600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory Syncytial Virus Infection-associated Hospitalization Rates in Infants and Children With Cystic Fibrosis.
    Metz J; Eber E; Resch B
    Pediatr Infect Dis J; 2017 Jun; 36(6):545-548. PubMed ID: 28005688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of influenza-associated hospitalizations in children in Germany.
    Weigl JA; Puppe W; Schmitt HJ
    Epidemiol Infect; 2002 Dec; 129(3):525-33. PubMed ID: 12558335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive and active immunization against respiratory syncytial virus for the young and old.
    Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.
    Wang D; Cummins C; Bayliss S; Sandercock J; Burls A
    Health Technol Assess; 2008 Dec; 12(36):iii, ix-x, 1-86. PubMed ID: 19049692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland.
    King JC; Lichenstein R; Cummings GE; Magder LS
    Vaccine; 2010 Nov; 28(49):7737-42. PubMed ID: 20933566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Respiratory syncytial virus in hospitalized children. A 3-year study].
    El-Hajje MJ; Moulin F; de Suremain N; Marc E; Cosnes-Lambe C; Pons-Catalano C; Lorrot M; Chalumeau M; Rozenberg F; Raymond J; Lebon P; Gendrel D
    Presse Med; 2008 Jan; 37(1 Pt 1):37-43. PubMed ID: 18061394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?
    Geskey JM; Ceneviva GD; Brummel GL; Graff GR; Javier MC
    Clin Ther; 2004 Dec; 26(12):2130-7. PubMed ID: 15823776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of alternative respiratory syndromes for specific syndromic surveillance of influenza and respiratory syncytial virus: a time series analysis.
    Schindeler SK; Muscatello DJ; Ferson MJ; Rogers KD; Grant P; Churches T
    BMC Infect Dis; 2009 Nov; 9():190. PubMed ID: 19943970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of winter epidemics of influenza and respiratory syncytial virus on paediatric admissions to an urban general hospital.
    Sugaya N; Mitamura K; Nirasawa M; Takahashi K
    J Med Virol; 2000 Jan; 60(1):102-6. PubMed ID: 10568771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.